Evidence map›Paper›PMID 28660850›Full record

ArticleThe British journal of nutrition2017

PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk.

Samara B Rifkin, Martha J Shrubsole, Qiuyin Cai, Walter E Smalley, Reid M Ness, Larry L Swift, Wei Zheng, Harvey J Murff

Open access · bronzeAbstract read
In one paragraph

Article in The British journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Samara B Rifkin1Division of Gastroenterology and Hepatology,Johns Hopkins University School of Medicine,1800 Orleans Street,Baltimore, MD 21287,USA.
Martha J Shrubsole2Division of Epidemiology,Vanderbilt University Medical Center,2525 West End Avenue,Suite 800,Nashville, TN 37203,USA.
Qiuyin Cai2Division of Epidemiology,Vanderbilt University Medical Center,2525 West End Avenue,Suite 800,Nashville, TN 37203,USA.
Walter E Smalley4Department of Health Policy,Vanderbilt University Medical Center,2525 West End Avenue,Suite 1200, Nashville, TN 37203,USA.
Reid M Ness5Division of Gastroenterology,Vanderbilt University Medical Center,1211 Medical Center Drive,Nashville, TN 37232,USA.
Larry L Swift6Department of Pathology, Microbiology and Immunology,Vanderbilt University Medical Center,1211 Medical Center Drive,Nashville, TN 37232,USA.
Wei Zheng2Division of Epidemiology,Vanderbilt University Medical Center,2525 West End Avenue,Suite 800,Nashville, TN 37203,USA.
Harvey J Murff3Geriatric Research Education and Clinical Center (GRECC),Department of Veterans Affairs,Tennessee Valley Healthcare System,1310 24th Avenue S,Nashville, TN 37212,USA.
Vanderbilt University Medical Center · USGeriatric Research Education and Clinical Center · USJohns Hopkins University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI ELASY, TOM A · 1986 to 2011
$28.1M
Tumor Markers and Recurrent Adenomas: A Follow-up StudyR01CA097386 · NCI · VANDERBILT UNIVERSITY · PI ZHENG, WEI · 2002 to 2006
$3.6M
Fatty acid desaturase activity, fish oil and colorectal cancer chemopreventionR01CA160938 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MURFF, HARVEY J. · 2011 to 2014
$1.3M
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm RiskR01CA143288 · NCI · VANDERBILT UNIVERSITY · PI MURFF, HARVEY J. · 2010 to 2013
$1.0M
NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA095103NCI NIH HHS R01 CA097386NCI NIH HHS R01 CA143288NCI NIH HHS R01 CA160938NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Dietary intake of PUFA has been associated with colorectal neoplasm risk; however, results from observational studies have been inconsistent. Most prior studies have utilised self-reported dietary measures to assess fatty acid exposure which might be more susceptible to measurement error and biases compared with biomarkers. The purpose of this study was to determine whether erythrocyte phospholipid membrane PUFA percentages are associated with colorectal adenoma risk. We included data from 904 adenoma cases and 835 polyp-free controls who participated in the Tennessee Colorectal Polyp Study, a large colonoscopy-based case-control study. Erythrocyte membrane PUFA percentages were measured using GC. Conditional logistic regression was used to calculate adjusted OR for risk of colorectal adenomas with erythrocyte membrane PUFA. Higher erythrocyte membrane percentages of arachidonic acid was associated with an increased risk of colorectal adenomas (adjusted OR 1·66; 95 % CI 1·05, 2·62, P trend=0·02) comparing the highest tertile to the lowest tertile. The effect size for arachidonic acid was more pronounced when restricting the analysis to advanced adenomas only. Higher erythrocyte membrane EPA percentages were associated with a trend towards a reduced risk of advanced colorectal adenomas (P trend=0·05). Erythrocyte membrane arachidonic acid percentages are associated with an increased risk of colorectal adenomas.

Indexed as

AdenomaArachidonic AcidBiomarkersCase-Control StudiesColorectal NeoplasmsDietEicosapentaenoic AcidErythrocyte MembraneFemaleHumansLogistic ModelsMaleMiddle AgedOdds RatioPhospholipidsRisk FactorsArachidonic AcidBiomarkersEicosapentaenoic AcidPhospholipidsaOR adjusted ORARA arachidonic acidCase–control studiesColorectal neoplasmsCRC colorectal cancerFatty acidsLA linoleic acidLC PUFA long-chain PUFANSAID non-steroidal anti-inflammatory drugs

Identifiers

PMID28660850
PMCPMC5891121
OpenAlexW2725224769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.